STEATOHEPATITIS

作品数：230被引量：1807H指数：21
导出分析报告
相关领域：医药卫生更多>>
相关作者：逯素梅马万山张艳美孙汭田志刚更多>>
相关机构：山东大学中国科学技术大学更多>>
相关期刊：更多>>
相关基金：国家自然科学基金国家重点基础研究发展计划瑞士科学基金河北省自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Metabolic dysfunction-associated steatotic liver disease and omega- 6 polyunsaturated fatty acids: Friends or foes
《World Journal of Hepatology》2025年第3期180-191,共12页Mona A Hegazy Safaa M Ahmed Shaimaa M Sultan Osama F Afifi Manal A Mohamed Alshimaa E Azab Mohamed A Hassanen Rakan K Zaben 
BACKGROUND Metabolic dysfunction-associated steatotic liver disease(MASLD)is the most common chronic liver disease worldwide.Its prevalence is closely linked to the dramatic rise in obesity and non-communicable diseas...
关键词：Metabolic dysfunction-associated steatotic liver disease Omega-6 polyunsaturated fatty acids Conjugated linoleic acid Arachidonic acid Lipid metabolism Oxidative stress STEATOHEPATITIS EICOSANOIDS 
Disparities in liver transplantation for metabolic dysfunctionassociated steatohepatitis-associated hepatocellular carcinoma
《World Journal of Transplantation》2025年第3期116-127,共12页David W Victor Sudha Kodali Mazen Noureddin Elizabeth W Brombosz Analisa Lopez Tamneet Basra Edward A Graviss Duc T Nguyen Ashish Saharia Ashton A Connor Maen Abdelrahim Yee Lee Cheah Caroline J Simon Mark J Hobeika Constance M Mobley R Mark Ghobrial 
BACKGROUND Metabolic dysfunction-associated steatohepatitis(MASH)is increasingly common,as is hepatocellular carcinoma(HCC)in the background of MASH.Liver transplantation(LT)provides superior long-term survival for pa...
关键词：Steatotic liver disease Liver neoplasms Ethnic and racial minorities Healthcare disparities Minority health 
How improvements in US FDA regulatory process and procedures led to the drug approval for first ever treatment of a common liver disease
《Acta Pharmacologica Sinica》2025年第3期515-524,共10页Brian E.Harvey 
Metabolic-associated liver disease is a growing public health crisis,with phenotypes from fatty liver to steatohepatitis,previously known as NASH(Non-Alcoholic SteatoHepatitis)and currently rebranded as MASH(Metabolic...
关键词：US Food&Drug Administration metabolic dysfunction-associated steatohepatitis MASH NASH type 2 diabetes mellitus DYSLIPIDEMIA 
Association between Helicobacter pylori infection and metabolic dysfunction-associated steatohepatitis:From an analysis of a population-based study
《World Journal of Hepatology》2025年第2期305-309,共5页Cheng-Fei Zhao 
Supported by Scientific Research Project of Putian University,No.2022059.
The growing global burden of metabolic dysfunction-associated steatohepatitis(MASH)demands a deeper understanding of its underlying mechanisms and risk factors.Recent studies,such as the large population-based case-co...
关键词：Helicobacter pylori infection Metabolic dysfunction-associated steatohepatitis Metabolic dysfunction-associated steatotic liver disease Non-alcoholic fatty liver disease Innovative research directions 
Induced pluripotent stem cell-derived mesenchymal stem cells for modeling and treating metabolic associated fatty liver disease and metabolic associated steatohepatitis:Challenges and opportunities
《World Journal of Stem Cells》2025年第2期17-28,共12页Bárbara Silva José Bragança 
American Heart Association Award,No.24IVPHA1288417;and FCT Fellowships,No.2022.13253.BDANA.
The potential of induced pluripotent stem cells(iPSCs)for modeling and treating metabolic associated fatty liver disease(MAFLD)and metabolic associated steatohepatitis(MASH)is emerging.MAFLD is a growing global health...
关键词：Metabolic associated fatty liver disease Metabolic associated steatohepatitis Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis Mesenchymal stem cells Induced pluripotent stem cells In vitro liver models 
Potential mechanisms and therapeutic prospects of the association between Helicobacter pylori infection and metabolic dysfunctionassociated steatohepatitis
《World Journal of Hepatology》2025年第1期178-182,共5页Guo-E Gou Ting Li Chen-Rui Liu Ting Meng Ya-Ping Li 
Supported by Basic and Clinical Integration Project of Xi’an Jiaotong University,No.YXJLRH2022067.
Helicobacter pylori(H.pylori)infection is a known inducer of various gastroin-testinal diseases,including gastritis,gastric ulcers,and gastric cancer.However,in recent years,research on the potential association betwe...
关键词：Helicobacter pylori Metabolic dysfunction-associated steatohepatitis Gut-liver axis Insulin resistance 
Helicobacter pylori infection as a contributing factor to metabolic dysfunction-associated steatohepatitis: A population-based insight
《World Journal of Hepatology》2025年第1期183-186,共4页Chao Li Jiang Nan Bo-Tao Xu 
This letter discusses the research conducted by Abdel-Razeq et al,highlighting a significant association between Helicobacter pylori(H.pylori)infection and me-tabolic dysfunction-associated steatohepatitis(MASH)in ind...
关键词：Helicobacter pylori Inflammation Insulin resistance Liver pathology Metabolic dysfunction-associated steatohepatitis 
Outbreak of metabolic dysfunction-associated steatohepatitis pharmacotherapies in 2024:From resmetirom to tirzepatide
《Chinese Medical Journal》2025年第2期127-129,共3页Rui Huang Chunli Zhang Xiaodong Mo Huiying Rao 
supported by the National Key Research&Development Program of China(No.2022YFA1303804);Peking University People’s Hospital Scientific Research Development Funds(No.RDJ2022-21);Peking University Hepatology Institute Qi-Min Project.
Metabolic dysfunction-associated steatotic liver disease(MASLD)is an increasingly common chronic liver disease with a global prevalence among adults exceeding 30%and approximately 1.66 billion cases worldwide as of 20...
关键词：chronic liver disease tirzepatide liver disease masld pharmacotherapies resmetirom 
Lipophagy and epigenetic alterations are related to metabolic dysfunction-associated steatotic liver disease progression in an experimental model
《World Journal of Hepatology》2024年第12期1468-1479,共12页Felipe Schütz Larisse Longo Melina Belén Keingeski Eduardo Filippi-Chiela Carolina Uribe-Cruz Mário Reis Álvares-da-Silva 
Supported by Financiamento e IncentivoàPesquisa from Hospital de Clínicas de Porto Alegre,No.2022-0117(toÁlvares-da-Silva MR);National Council for Scientific and Technological Development,No.CNPq(to Alvares-da-Silva MR);Coordination for the Improvement of Higher Education Personnel,No.CAPES/PNPD.
BACKGROUND Genetic and epigenetic alterations are related to metabolic dysfunction-associated steatotic liver disease(MASLD)pathogenesis.AIM To evaluate micro(mi)RNAs and lipophagy markers in an experimental model of ...
关键词：Animal model EPIGENETIC Lipophagy MicroRNAs Metabolic dysfunction-associated steatotic liver disease Metabolic dysfunction-associated steatohepatitis 
Exploring non-invasive diagnostics and non-imaging approaches for pediatric metabolic dysfunction-associated steatotic liver disease
《World Journal of Gastroenterology》2024年第47期5070-5075,共6页Toshifumi Yodoshi 
In this article,we comment on the article by Qu and Li,focusing specifically on the non-invasive diagnostic approaches for metabolic dysfunction-associated steatotic liver disease(MASLD).MASLD is the most common chron...
关键词：Non-alcoholic fatty liver disease Non-alcoholic steatohepatitis Metabolic dysfunction-associated steatotic liver disease Metabolic dysfunction-associated steatohepatitis Insulin resistance Oxidative stress 
全选清除导出
共23页<12345678910>
检索报告 对象比较 聚类工具 使用帮助 返回顶部